EcoDrugPlus

Integrin Beta-1-Like

Ensembl ID : ENSSPAG00000015925
Gene Symbol: LOC103366961
3 Cross references
211 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSPAG00000015875
Gene Symbol: LOC103366491
3 Cross references
201 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSPAG00000003048
Gene Symbol: LOC103364929
3 Cross references
194 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSSPAG00000011809
Gene Symbol: ITGA2B
3 Cross references
190 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSPAG00000008620
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSSPAG00000010899
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSSPAG00000006628
Gene Symbol: ITGAV
3 Cross references
232 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSPAG00000018910
Gene Symbol: ITGB1
3 Cross references
228 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSSPAG00000005338
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSPAG00000005959
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSSPAG00000018494
Gene Symbol: ITGB5
1 Cross references
204 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSPAG00000021849
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).